Screener
Sarepta Therapeutics, Inc. SRPT Other Nonrecurring Income Expense
Other Nonrecurring Income Expense at other companies
Other financials
Where this comes from
Reported directly by Sarepta Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherNonrecurringIncomeExpense.
The source filing: Sarepta Therapeutics, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 4:01 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-335003
| Line item | For the Three Months Ended June 30, 2026 | For the Three Months Ended June 30, 2025 | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|---|---|
| Interest income | $6,207 | $5,254 | $12,567 | $15,444 |
| Accretion of investment discount, net | 955 | 1,887 | 1,597 | 4,125 |
| Interest expense | (21,508) | (5,228) | (43,221) | (9,731) |
| (Loss) gain on strategic investments | (448) | 36,721 | (2,160) | (54,007) |
| Other, net | (246) | (573) | 918 | (902) |
| Total other (expense) income, net | $(15,040) | $38,061 | $(30,299) | $(45,071) |
Item 1. Financial Statements
FAQ
- What is Sarepta Therapeutics, Inc.'s other nonrecurring income expense?
- Sarepta Therapeutics, Inc. (SRPT) reported other nonrecurring income expense of $246K in Q2 2026.
- What does other nonrecurring income expense mean?
- Other Nonrecurring Income Expense
Ask your AI about Sarepta Therapeutics, Inc.'s other nonrecurring income expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude